InMode shares surge 10.61% after-hours on $1.1B foreign acquisition rumors and formal sale process initiation.
ByAinvest
Monday, Jan 26, 2026 4:37 pm ET1min read
INMD--
InMode Ltd. surged 10.61% in after-hours trading following reports that the Israeli medical aesthetics firm is in advanced negotiations for a $1.1 billion acquisition by a foreign investment fund. The proposed deal, representing a 25% premium over its current valuation, triggered immediate buying activity, with shares rising 14% in premarket trading earlier in the week. The company has engaged Bank of America to oversee the sale process, signaling a strategic shift toward a potential exit. While the acquisition rumors provided a short-term catalyst, the stock remains down 5% year-to-date amid broader concerns about declining revenue and operating margins. The key driver of the after-hours rally was the confirmation of a credible bid at a significant premium, aligning with the stock’s sharp upward move.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet